Abstract:Background Recent studies have discovered that nuclear translocation of nerve growth factor (NGF) and its receptor fragments function differently from the traditional model. This study aimed to uncover the nuclear expression of NGF in astrocytoma and its biological significance.Methods Ninety-four paraffin-embedded astrocytoma specimens were subjected to immunohistochemical (IHC) and hemotoxylin & eosin (HE) staining. Preoperative cerebrospinal fluid (CSF) specimens and intraoperative snap-frozen astrocytoma tissues were assayed for NGF expression by ELISA and Western blotting. The outcome of patients who contributed samples was tracked. Each ten tissue samples from patients with traumatic brain injury who had received decompression surgery and CSF samples from patients undergoing spinal anesthesia but with no history of nervous system disease were taken as control.Results NGF-positive immunoreactive products were distributed in both the cytoplasm and nucleus of astrocytoma, but were only located in the cytoplasm of traumatic brain injury (TBI) tissue. NGF nuclear-positive rate (NPR) of grades III-IV astrocytomas (70.0%) was higher than that of grades I-II astrocytoma (28.6%, P <0.05). NGF-NP expression positively correlated with the NGF concentration in cerebrospinal fluid (CSF) (r=0.755, P <0.01). Kaplan-Meier survival analysis indicated that the median survival time was 25 months for NGF-NP astrocytoma grade I-II patients and 42 months in NGF nuclear negative (NGF-NN) astrocytoma grade I-II patients (P <0.05). In astrocytoma III-IV patients, the median survival was 7 months for NGF-NP patients and 24 months for NGF-NN patients (P <0.01). Two types of NGF with molecular weights of 13 and 36 kDa were present in astrocytoma, but only the 36 kDa NGF was found in the CSF. NGF expression elevated as the malignancy increased.Conclusions NGF-NP expression and NGF level in CSF were significant prognostic factors in astrocytoma patients. Because of the easy access of CSF, it may be developed as an index for early diagnosis and surveillance of astrocytoma. Chin Med J 2011;124(14):2222-2227

Neuritin expression and its relation with proliferation, apoptosis, and angiogenesis in human astrocytoma

Expression of Endothelial Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Association with Neovascularization in Human Primary Astrocytoma.

Expression of Enos and VEGF in Association with Angiogenesis of Human Astrocytoma

Microrna-182 Inhibits the Proliferation and Migration of Glioma Cells Through the Induction of Neuritin Expression.

Nerve Growth Factor Expression in Astrocytoma and Cerebrospinal Fluid: a New Biomarker for Prognosis of Astrocytoma.

Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma

P01.23 * NEUROTENSIN PROMOTES THE PROGRESSION OF MALIGNANT GLIOMA THROUGH NTSR1 AND IMPACTS THE PROGNOSIS OF GLIOMA PATIENTS

Expression of CD133 and Nestin in Human Astrocytic Tumor and its Pathological Grade

The Use of Three Long Non-Coding RNAs As Potential Prognostic Indicators of Astrocytoma

Apoptosis in Supratentorial Astrocytomas and Expression of Apoptosis Related Gene P53 and Bcl-2

Proliferative Status of Tumor Stem Cells May Be Correlated with Malignancy Grade of Human Astrocytomas

Expression of Neural Cell Adhesive Molecule in Human Brain Astrocytoma

Expression of Nogo-66 Receptor in Human Astrocytoma is Correlated with Tumor Malignancy

Role of Urokinase-type Plasminogen Activator and Vascular Endothelial Growth Factor and the Correlation in Human Astrocytomas Invasion

Expression of brain-specific angiogenesis inhibitor 1 is inversely correlated with pathological grade, angiogenesis and peritumoral brain edema in human astrocytomas

Neurotensin Promotes the Progression of Malignant Glioma Through Ntsr1 and Impacts the Prognosis of Glioma Patients

Expression and significance of Neuropilin-1 and CD4+ CD25+ Treg in human gliomas

The Use of Hsa-Mir-21, Hsa-Mir-181b and Hsa-Mir-106a As Prognostic Indicators of Astrocytoma.

Expression and Significance of LRIG1 Gene in Human Astrocytomas

Expression of Stem Cell Markers in Human Astrocytomas of Different Who Grades

MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma